Concepedia

Giorgio Valabrega

GV

Statistics

Publications

44

Citations

2.5K

H-Index

22

Active since

2003

Affiliations

University of Turin(Current)

Candiolo Cancer Institute

Istituti di Ricovero e Cura a Carattere Scientifico

A. O. Ordine Mauriziano di Torino

Agostino Gemelli University Polyclinic

Giorgio Valabrega is an author at University of Turin specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2003–2024

44

Publications

44

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

Mansoor Raza Mirza, Dana M. Chase, Brian M. Slomovitz et al. · New England Journal of Medicine · 2023 · 718 citations · Full text

Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy

Eleonora Ghisoni, Alexandre Wicky, Hasna Bouchaab et al. · European Journal of Cancer · 2021 · 180 citations · Full text

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García et al. · The Lancet · 2023 · 175 citations

, , +6

TGFα expression impairs Trastuzumab-induced HER2 downregulation

Giorgio Valabrega, Filippo Montemurro, Ivana Sarotto et al. · Oncogene · 2005 · 128 citations

, , +4

Outcome of Patients with HER2-Positive Advanced Breast Cancer Progressing During Trastuzumab-Based Therapy

Filippo Montemurro, Michela Donadio, Matteo Clavarezza et al. · The Oncologist · 2006 · 128 citations · Full text

1–5 of 44